published in Translational Lung Cancer Research, June 16, 2017
A review of the most promising biomarkers for early detection of malignant mesothelioma.
Nature International Weekly Journal of Science (2017) - doi:10.1038/nature22798
A mechanistic rationale for the ability of BAP1 to regulate gene-environment interaction in human carcinogenesis
A Review of our Projects, Publications, and Discoveries
Annals of Translational Medicine 2017: Review Article
Recent discoveries have elucidated some of the mechanisms responsible for the development of mesothelioma.
Journal of Translational Medicine
Malignant mesothelioma (MM) is a very aggressive type of cancer, with a dismal prognosis and inherent resistance to chemotherapeutics. Development and evaluation of new therapeutic approaches is highly needed. Immunosuppressant FTY720, approved for multiple sclerosis treatment, has recently raised attention for its anti-tumor activity in a variety of cancers. However, its therapeutic potential in MM has not been evaluated yet.